Risheng Que
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
- Cancer Cells and Metastasis
Papers in
- Oncology 24
- Pancreatic and Hepatic Oncology Research 19
- Cancer Immunotherapy and Biomarkers 2
-
- Renal cell carcinoma treatment 6
- Sarcoma Diagnosis and Treatment 2
- Co-authors
- Guoping Ding (6 shared papers)Liping Cao (5 shared papers)Jionghuang Chen (1 shared paper)Shunliang Gao (27 shared papers)Tingbo Liang (21 shared papers)Xiang Li (11 shared papers)Xueli Bai (15 shared papers)Liping Cao (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Cancer Letters (4 papers)Journal of Zhejiang University SCIENCE B (4 papers)HPB (2 papers)Pancreatology (2 papers)
- Partner nations
- ChinaUnited StatesMadagascar
In The Last Decade
Risheng Que
46 papers receiving 974 citations
Peers
Comparison fields: 5 of 68
- Cancer Research 397
- Oncology 389
- Hepatology 53
- Transplantation 15
- Molecular Biology 366
Countries citing papers authored by Risheng Que
This map shows the geographic impact of Risheng Que's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Risheng Que with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Risheng Que more than expected).
Fields of papers citing papers by Risheng Que
This network shows the impact of papers produced by Risheng Que. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Risheng Que. The network helps show where Risheng Que may publish in the future.
Co-authors
The 25 scholars most cited alongside Risheng Que, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 228 | |
| 2 | 2019 | 106 | |
| 3 | 2018 | 74 | |
| 4 | 2016 | 68 | |
| 5 | 2017 | 47 | |
| 6 | 2018 | 43 | |
| 7 | 2015 | 38 | |
| 8 | 2010 | 36 | |
| 9 | 2014 | 31 | |
| 10 | 2019 | 29 | |
| 11 | 2018 | 24 | |
| 12 | 2019 | 24 | |
| 13 | 2008 | 18 | |
| 14 | 2020 | 17 | |
| 15 | 2023 | 17 | |
| 16 | 2015 | 15 | |
| 17 | 2020 | 15 | |
| 18 | 2023 | 14 | |
| 19 | 2008 | 13 | |
| 20 | 2020 | 12 |
About Risheng Que
Risheng Que is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Cancer Research and Surgery, having authored 47 papers that have together received 995 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (9 papers), Cancer Genomics and Diagnostics (8 papers), Renal cell carcinoma treatment (6 papers), Sarcoma Diagnosis and Treatment (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Cancer Research (397 citations), Oncology (389 citations), Hepatology (53 citations), Transplantation (15 citations) and Molecular Biology (366 citations). Risheng Que has collaborated with scholars based in China, United States and Madagascar. Frequent co-authors include Guoping Ding, Liping Cao, Jionghuang Chen, Shunliang Gao, Tingbo Liang, Xiang Li, Xueli Bai, Liping Cao, Jianying Lou and Tao Ma. Their work appears in journals such as Journal of Clinical Oncology, Cancer Letters, Journal of Zhejiang University SCIENCE B, HPB and Pancreatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.